Sumitomo Mitsui Trust Group
GNOM icon

Sumitomo Mitsui Trust Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.29M Buy
+93,103
New +$4.44M ﹤0.01% 722

Other funds holding GNOM

CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group's GNOM Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 93,103 shares worth $5.29M. The stake represents ﹤0.01% of the portfolio and ranks #722 among its holdings.

17 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 93,103 shares of Global X Genomics & Biotechnology ETF worth $5.29M as of Q2 2026.
  • Global X Genomics & Biotechnology ETF was a new Sumitomo Mitsui Trust Group position in Q2 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #722 holding.
  • 17 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.